These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22835796)

  • 1. Epinephrine autoinjector warning.
    Hawkins SC; Weil C; Fitzpatrick D
    Wilderness Environ Med; 2012 Dec; 23(4):371-2. PubMed ID: 22835796
    [No Abstract]   [Full Text] [Related]  

  • 2. Anaphylaxis treatment: ergonomics of epinephrine autoinjector design.
    Dennerlein JT
    Am J Med; 2014 Jan; 127(1 Suppl):S12-6. PubMed ID: 24384133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of epinephrine autoinjectors for treatment of anaphylaxis: which commercially available autoinjector do patients prefer?
    Baker TW; Stolfi A; Johnson TL
    Ann Allergy Asthma Immunol; 2009 Oct; 103(4):356-8. PubMed ID: 19856492
    [No Abstract]   [Full Text] [Related]  

  • 4. Empowering patients with a history of anaphylaxis to use an epinephrine autoinjector without fear.
    Rosen JP
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):418. PubMed ID: 17042151
    [No Abstract]   [Full Text] [Related]  

  • 5. Training of trainers on epinephrine autoinjector use.
    Arga M; Bakirtas A; Catal F; Derinoz O; Harmanci K; Razi CH; Ergöcen S; Demirsoy MS; Turktas I
    Pediatr Allergy Immunol; 2011 Sep; 22(6):590-3. PubMed ID: 21309857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Make-up of the epinephrine autoinjector: the effect on its use by untrained users.
    Bakirtas A; Arga M; Catal F; Derinoz O; Demirsoy MS; Turktas I
    Pediatr Allergy Immunol; 2011 Nov; 22(7):729-33. PubMed ID: 21749463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indication for adrenalin autoinjector after anaphylaxis].
    Malling HJ; Hansen KS; Mosbech H
    Ugeskr Laeger; 2012 Jun; 174(25):1741-3. PubMed ID: 22713223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability of epinephrine auto-injectors and knowledge of community pharmacists about their use.
    Pitsios C; Vasiliadis A; Karakatsanis KP; Matzaras R; Minasidis T; Nteveros A; Samanis G; Nikolopoulos G
    Eur Ann Allergy Clin Immunol; 2019 Sep; 51(5):234-236. PubMed ID: 31523943
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of epinephrine autoinjector design on unintentional injection injury.
    Arga M; Bakirtas A; Topal E; Yilmaz O; Hacer Ertoy Karagol I; Demirsoy MS; Turktas I
    Allergy Asthma Proc; 2012; 33(6):488-92. PubMed ID: 23394506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self vs partnered epinephrine autoinjector training, performance differences in an anaphylaxis simulation.
    Kaminski AE; Li Z; Dike NO; Gonzalez-Estrada A; Simon LV
    Ann Allergy Asthma Immunol; 2021 Mar; 126(3):304-306. PubMed ID: 33359453
    [No Abstract]   [Full Text] [Related]  

  • 11. Human factors study in untrained adolescents comparing a recently approved single-dose epinephrine prefilled syringe with an approved autoinjector.
    Moss RB; Daniels K; Moll T; Carlo DJ
    Ann Allergy Asthma Immunol; 2018 May; 120(5):540-541. PubMed ID: 29499368
    [No Abstract]   [Full Text] [Related]  

  • 12. A simple method to improve safety of epinephrine auto-injectors.
    Kränke B; Schuster C; Wiednig M; Reiter H
    Pediatr Allergy Immunol; 2012 Jun; 23(4):399-400. PubMed ID: 22594931
    [No Abstract]   [Full Text] [Related]  

  • 13. Adrenaline autoinjectors in food allergy: in for a cent, in for a euro?
    Niggemann B; Beyer K
    Pediatr Allergy Immunol; 2012 Sep; 23(6):506-8. PubMed ID: 22906368
    [No Abstract]   [Full Text] [Related]  

  • 14. Improving adrenaline autoinjector adherence: A psychologically informed training for healthcare professionals.
    Mahoney B; Walklet E; Bradley E; O'Hickey S
    Immun Inflamm Dis; 2019 Sep; 7(3):214-228. PubMed ID: 31290265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epinephrine administration: an action plan.
    White EA
    Nurse Pract; 2010 Mar; 35(3):33-9. PubMed ID: 20164734
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of self-administered epinephrine during a training session.
    Hellstrom A; Eriksson K; Efraimsson EO; Svedmyr J; Borres MP
    Acta Paediatr; 2011 Jul; 100(7):e34-5. PubMed ID: 21635360
    [No Abstract]   [Full Text] [Related]  

  • 17. Current practices among allergists on writing self-injectable epinephrine prescriptions for immunotherapy patients.
    Gupta P; Gerrish PK; Silverman B; Schneider A
    J Allergy Clin Immunol; 2012 Feb; 129(2):571-2, 572.e1-2. PubMed ID: 22036248
    [No Abstract]   [Full Text] [Related]  

  • 18. PHARMAC and EpiPen for anaphylaxis.
    Moodie P; Metcalfe S; Dougherty S
    N Z Med J; 2006 Jun; 119(1236):U2038. PubMed ID: 16807580
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pain estimation caused by adrenaline injectors for the treatment of anaphylaxis. The recommendation to practice the use prior to acute allergic reaction is supported by a cross-sectional study].
    Zara K; Hellman BM; Zetterström O
    Lakartidningen; 2008 May 7-13; 105(19):1388-90. PubMed ID: 18574977
    [No Abstract]   [Full Text] [Related]  

  • 20. First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen).
    Gold MS; Sainsbury R
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):171-6. PubMed ID: 10887321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.